Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities
Garrett W. Cooper, Andrew L. Hong
Cancers (2022) Vol. 14, Iss. 15, pp. 3645-3645
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Targeting SWI/SNF Complexes in Cancer: Pharmacological Approaches and Implications
Megan R. Dreier, Jasmine Walia, Ivana L. de la Serna
Epigenomes (2024) Vol. 8, Iss. 1, pp. 7-7
Open Access | Times Cited: 9
High-throughput screening of human genetic variants by pooled prime editing
Michael Herger, Christina M. Kajba, Megan Buckley, et al.
Cell Genomics (2025), pp. 100814-100814
Open Access | Times Cited: 1
Inflammatory Networks in Renal Cell Carcinoma
Linus Kruk, Medina Mamtimin, Attila Braun, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2212-2212
Open Access | Times Cited: 19
Genome-guided discovery of cancer therapeutic targets
Prathyusha Konda, Simon Garinet, Eliezer M. Van Allen, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112978-112978
Open Access | Times Cited: 14
Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors
Cinzia Lanzi, Noemi Arrighetti, Sandro Pasquali, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115727-115727
Closed Access | Times Cited: 13
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology
Wan Ying Tan, Snigdha Nagabhyrava, Olivia Ang-Olson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6533-6565
Open Access | Times Cited: 4
SMARCB1/INI-1-Deficient sinonasal carcinoma demonstrates a poor prognosis but favorable clinical outcomes after PD-1/PD-L1 inhibitor therapy: A case series
Shuhan Zhao, Hao Du, Zhanjie Zhang, et al.
Science Progress (2025) Vol. 108, Iss. 1
Open Access
SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1
Octavio A. Trejo-Villegas, Priscila Pineda-Villegas, Leonel Armas‐López, et al.
Cancer Gene Therapy (2025)
Open Access
Predicting high-risk clinical missense variants of SMARCB1 in rare neurogenetic disorder schwannomatosis (nerve tumor) through sequence, structure, and molecular dynamics analyses
Mitesh Patel, Reem Binsuwaidan, Malvi Surti, et al.
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access
Head and neck tumours with neuroendocrine marker ‘expression’: pitfalls and learning points
Ella-Grace Kirton, Karwan Moutasim
Diagnostic histopathology (2025)
Closed Access
Effects of Induced Pluripotent Stem Cell-Derived Astrocytes on Cisplatin Sensitivity in Pediatric Brain Cancer Cells
Sonia Kiran, Yu Xue, Drishty B. Sarker, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 997-997
Open Access
SMARCB1 Deficiency as a Driver of the Hallmarks of Cancer in Rhabdoid Tumours: Novel Insights into Dysregulated Energy Metabolism, Emerging Targets, and Ongoing Clinical Trials
Abdul L. Shakerdi, Graham P. Pidgeon
Metabolites (2025) Vol. 15, Iss. 5, pp. 304-304
Open Access
Beyond SMARCB1 Loss: Recent Insights into the Pathobiology of Epithelioid Sarcoma
Elisa Del Savio, Roberta Maestro
Cells (2022) Vol. 11, Iss. 17, pp. 2626-2626
Open Access | Times Cited: 18
Interconversion of Cancer Cells and Induced Pluripotent Stem Cells
Drishty B. Sarker, Yu Xue, Faiza Mahmud, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 125-125
Open Access | Times Cited: 3
Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies
Sarah Andres, Karen Huang, Margaret Shatara, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 6
Closed Access | Times Cited: 3
High-throughput screening of human genetic variants by pooled prime editing
Michael Herger, Christina M. Kajba, Megan Buckley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Preclinical evidence in the assembly of mammalian SWI/SNF complexes: Epigenetic insights and clinical perspectives in human lung disease therapy
Octavio A. Trejo-Villegas, Irene H. Heijink, Federico Ávila-Moreno
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2470-2488
Closed Access | Times Cited: 3
SMARCB1-deficient sinonasal adenocarcinoma: a rare variant of SWI/SNF-deficient malignancy often misclassified as high-grade non-intestinal-type sinonasal adenocarcinoma or myoepithelial carcinoma
Alena Skálová, Touraj Taheri, Martina Bradová, et al.
Virchows Archiv (2023) Vol. 485, Iss. 2, pp. 245-256
Open Access | Times Cited: 9
SWI/SNF-deficient Sinonasal Carcinomas
Abbas Agaimy
Advances in Anatomic Pathology (2022) Vol. 30, Iss. 2, pp. 95-103
Closed Access | Times Cited: 14
Acquired cystic disease associated renal cell carcinoma: A clinicopathologic and molecular study of 31 tumors
Ejas Palathingal Bava, Joseph Sanfrancesco, Ahmed Alkashash, et al.
Human Pathology (2024) Vol. 149, pp. 48-54
Closed Access | Times Cited: 2
SMARCB1/INI1-deficient undifferentiated tumour of the thorax: a case report and review of the literature
Moreno Zagni, Alessandro Marando, Mariachiara Negrelli, et al.
Pathologica (2024) Vol. 116, Iss. 3, pp. 163-169
Open Access | Times Cited: 2
Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations
Pooja Navale, Deyali Chatterjee, Malak Itani, et al.
Virchows Archiv (2023) Vol. 483, Iss. 2, pp. 167-175
Closed Access | Times Cited: 5
Genomic alterations and diagnosis of renal cancer
Xingming Zhang, Hella Anna Bolck, Niels J. Rupp, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 323-337
Open Access | Times Cited: 5
The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies
Ibolya Czegle, Chelsea X. Huang, Priscilla Geraldine Soria, et al.
Life (2023) Vol. 13, Iss. 4, pp. 996-996
Open Access | Times Cited: 4
Molecularly Defined Thoracic Neoplasms
Anja C. Roden
Advances in Anatomic Pathology (2024) Vol. 31, Iss. 5, pp. 303-317
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top